SecBot SecBot
SECBOTREPLAY Home › Report › BCRX

BCRX · Director Theresa Heggie sold 49,933 shares of BioCryst Pharmaceuticals…

BIOCRYST PHARMACEUTICALS INC · CLUSTER filed Mar 15, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 15, 2026 at 20:00 ET

Director Theresa Heggie sold 49,933 shares of BioCryst Pharmaceuticals for $504,823 in an open-market transaction. This sale was accompanied by the exercise of derivative securities related to the same share amount, including a non-cash exercise. The total open-market sale represents a modest but notable insider disposition.

  • Director Theresa Heggie sold 49,933 shares at $10.11 per share for total proceeds of $504,823.
  • On the same day, she exercised derivative securities for 99,866 shares (two separate exercises: one at $6.30 and one at $0 strike price).
  • Only the open-market sale (Form 4 code 'S') represents a cash transaction; the derivative exercises (code 'M') are non-cash events and do not reflect new investment or direct selling pressure.
  • Total open-market selling in the past 7 days: $504,823 (one insider). Recent 30-day selling totals $1.9M across two insiders.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access